APA (7th ed.) Citation

Ni, L., Zhu, X., Zhao, Q., Shen, Y., Tao, L., Zhang, J., . . . Zhu, W. (2024). Dihydroartemisinin, a potential PTGS1 inhibitor, potentiated cisplatin-induced cell death in non-small cell lung cancer through activating ROS-mediated multiple signaling pathways. Neoplasia (New York, N.Y.), 51, 100991. https://doi.org/10.1016/j.neo.2024.100991

Chicago Style (17th ed.) Citation

Ni, Lianli, et al. "Dihydroartemisinin, a Potential PTGS1 Inhibitor, Potentiated Cisplatin-induced Cell Death in Non-small Cell Lung Cancer Through Activating ROS-mediated Multiple Signaling Pathways." Neoplasia (New York, N.Y.) 51 (2024): 100991. https://doi.org/10.1016/j.neo.2024.100991.

MLA (9th ed.) Citation

Ni, Lianli, et al. "Dihydroartemisinin, a Potential PTGS1 Inhibitor, Potentiated Cisplatin-induced Cell Death in Non-small Cell Lung Cancer Through Activating ROS-mediated Multiple Signaling Pathways." Neoplasia (New York, N.Y.), vol. 51, 2024, p. 100991, https://doi.org/10.1016/j.neo.2024.100991.